Related Experiment Video
Updated: Aug 25, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
The AMSP drug safety program: methods and global results
R Grohmann1, R R Engel, E Rüther
1Department of Psychiatry, Ludwig-Maximilians University of Munich, Munich, Germany. Renate.Grohmann@med.uni-muenchen.de
Abstract:
The AMSP (Arzneimittelsicherheit in der Psychiatry) study is a drug safety program that ensures the continuous assessment of severe adverse drug reactions (ADR) in psychiatric inpatients under the natural conditions of routine clinical treatment. It developed out of the preceding drug surveillance study AMUP (Arzneimittelüberwachung in der Psychiatrie). Currently 35 hospitals participate in the study. This paper describes the methods of the AMSP, gives detailed definitions of ADRs assessed to be "severe," and discusses the implications of these definitions and the methodological approach for evaluating the AMSP data. In addition, some overall data compiled on ADR rates from 1993 to 2000 are given.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Therapeutic Drug Monitoring: Drug Analysis Methods
FDA Approved Drugs: Changes to Approved Drugs
Pharmaceutical Poisoning: Potential Scenarios
Drug Control Governance: Regulatory Bodies and Their Impact